drugset / Trial / NCT01519726

CYP3A4 Metabolism Before and After Surgery Induced Weight Loss Using Midazolam as Model Drug

NCT01519726

Phase 4 Completed 20 enrolled St. Antonius Hospital

Summary

Before and during bariatric surgery patients are given oral and i.v. midazolam, respectively and blood samples are drawn to establish midazolam time-concentration profiles. After 0.5-2 years, and substantial weight loss, oral and i.v. midazolam are administered once more and blood samples are taken again.

Timeline

Start
2011-12
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Midazolam Small molecule Oral

Indications